More info
Release form
Pills
Composition
1 tab. Dry Novo-Passit extract (obtained from rhizomes with roots of valerian medicinal, melissa herb, Hypericum perforatum, hollow leaves and flowers of single-pest or common hawthorn, Pasciflora incarnate herb (passionflower), common hop fruit, black elderberry) 157.5 g,
Pharmacological effect
Combined herbal remedy with a sedative effect, pharmacological activity due to its constituent components of the extract based on medicinal raw materials with a predominantly sedative effect and guaifenesin, which has an anxiolytic effect. The sedative effect of the drug is supplemented by the anxiolytic effect of guaifenesin.
Pharmacokinetics
The action of the drug Novo-Passit is the cumulative effect of its components, therefore, conducting kinetic studies is not possible.
Indications
Neurasthenia and neurotic reactions accompanied by irritability, anxiety, fear, fatigue, absent-mindedness. Manager's syndrome (state of constant mental stress). Insomnia (mild forms). Headaches caused by nervous tension. Migraine. Functional diseases of the gastrointestinal tract (dyspeptic syndrome, irritable bowel syndrome). As a symptomatic remedy for neurocirculatory dystonia and menopausal syndrome. Dermatitis (atopic and seborrheic eczema, beer-house), due to psychological stress.
Contraindications
Hypersensitivity to the components of the drug, especially guaifenesin, myasthenia gravis, children under 12 years old. With care: acute diseases of the gastrointestinal tract, liver disease, alcoholism, diseases or injuries of the brain, epilepsy.
Precautionary measures
The drug should be used with caution in patients with acute gastrointestinal diseases, liver diseases, chronic alcoholism, diseases and injuries of the brain, and epilepsy.
Use during pregnancy and lactation
In pregnancy, the drug is prescribed only by absolute indications, if the expected benefit of therapy for the mother exceeds the possible risk to the fetus.If necessary, the use of the drug during lactation breastfeeding should be discontinued.
Dosage and administration
Inside, adults and children over 12 years old. In the absence of other recommendations of the doctor, the drug should be taken 1 tablet 3 times a day before meals. After consulting a doctor, it is possible to increase the dose up to 2 pills 3 times a day. With the appearance of severe fatigue or depression, it is necessary to reduce the morning and daily dose to 1/2 tablet at the reception in the morning and afternoon, in the evening take 1 tablet. The interval between doses should be 4-6 hours. In case of nausea, the drug should be taken with food.
Side effects
Patients usually tolerate the drug well. However, in rare cases, allergic reactions, rash, dizziness, fatigue, drowsiness, mild muscle weakness, disorders of the gastrointestinal tract (nausea, vomiting, spasms, heartburn, diarrhea, constipation), decreased concentration, which quickly disappear after drug withdrawal . If these or other side effects occur, you should consult a doctor.
Overdose
Symptoms: first - drowsiness, feeling of depression, later - nausea, mild muscle weakness, pain in the joints, feeling of heaviness in the stomach. Treatment: gastric lavage, symptomatic therapy. The patient should be warned about the need to see a doctor.
Interaction with other drugs
While taking the drug Novo-Passit and other drugs, their action may be enhanced or weakened. Before taking the drug at the same time as other drugs, the patient should consult a doctor. The drug enhances the action of ethanol and other substances that have a depressant effect on the central nervous system. Drugs used to relax skeletal muscles (central muscle relaxation) can increase the risk of side effects of the drug, first of all - muscle weakness. The herb extract Hypericum perforatum contained in the drug reduces the effectiveness of hormonal contraception, as well as drugs used mainly after transplantation to reduce the risk of rejection of the transplanted organ or tissue (immunosuppressants), drugs for the treatment of AIDS, cardiovascular diseases, bronchial diseases and prevention of thromboembolism . Therefore, before taking the drug Novo-Passit on the background of these drugs, the patient should consult with your doctor.
special instructions
During the period of treatment with Novo-Passit, alcohol should not be consumed. With caution should use the drug in acute gastrointestinal diseases. The patient should be warned that if within 7 days of therapy the symptoms of the disease do not disappear or their strengthening occurs, it is recommended to consult a doctor. While taking the drug Novo-Passit should avoid exposure to ultraviolet radiation (prolonged exposure to direct sunlight, visiting the tanning bed), especially for patients with fair skin. The drug in the form of a solution is not recommended for use in patients with impaired glucose uptake and galactose and congenital fructose intolerance. Patients with diabetes should be borne in mind that 100 g of the oral solution contains 12.5-14.2 g of glucose and 13.6-15.3 g of fructose. When taken in recommended doses, each dose contains not more than 1.42 g of glucose and 1.53 g of fructose. Oral solution contains 12.19% ethanol; each single dose contains up to 0.481 g of ethanol. Impact on the ability to drive motor vehicles and control mechanisms: During the period of treatment, it is necessary to refrain from engaging in potentially hazardous activities that require increased concentration of attention and quickness of psychomotor reactions. Do not drive vehicles and mechanisms.